Ten years after Kalief Browder’s death by suicide, his story lingers as a reminder of both the horrors of New York City’s ...

A revealing memoir from one of Australia's most beloved authors and an exciting debut about a literary fraudster in the ...

Nerandomilast slowed lung function decline in people with IPF and PPF after a year of treatment, according to data from two ...

Using disease-modifying therapies in MS tends to reduce the risk of stroke, though effects vary depending on the type of DMT, ...

Your CBD Store® stands in firm opposition to Texas Senate Bill 3 (SB 3), which threatens the livelihood of thousands of small and independent Texas merchants and business owners and denies access to a ...

Chronic inflammatory bowel disease is challenging to treat and carries a risk of complications, including the development of ...

The global Phenylketonuria (PKU) Treatment is undergoing a strategic transformation, driven by novel drug candidates and a more targeted understanding of unmet clinical needs. With a global prevalence ...

This online-only abstract outlines a Project Optimus-aligned approach to define the optimal therapeutic window of PCS11T, a ...

Chronic inflammatory bowel disease is challenging to treat and carries a risk of complications, including the development of ...

CI Insights From Zepbound to AD109, pharma innovation is reshaping Obstructive Sleep Apnea. Discover key players, C ...

Roche presented promising 96-week data from the Phase II FENopta study, showing that its investigational drug, fenebrutinib, significantly reduce ...

A blood test could soon help diagnose dementia. A new trial is underway in Dorset to explore the potential of blood tests to improve diagnosis rates. The study is taking place at Dorset HealthCare ...